Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Am J Transl Res ; 14(6): 4207-4228, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35836882

RESUMEN

BACKGROUND: Prior reports have indicated that the abnormal expression of small nuclear ribonucleoproteins (snRNPs) genes is related to malignant tumors. However, in hepatocellular carcinoma (HCC), the precise role of snRNPs is not well understood. Therefore, the purpose of this study was to evaluate the prognostic roles of SNRPB/D1/D2/D3/E/F/G and their correlation to immune infiltration in HCC. METHODS: The study was carried out via the following databases, software, and experimental validation: ONCOMINE, GEPIA2, UALCAN, The Cancer Genome Atlas, Gene Expression Omnibus, ArrayExpress, Kaplan-Meier plotter, cBioPortal, STRING, DAVID 6.8, TIMER, Cytoscape software, and immunohistochemistry experiments. RESULTS: Overexpressed SNRPB/D1/D2/D3/E/F/G proteins were found in HCC tissues. The transcription levels of 7 snRNPs genes were related to the TP53 mutation and tumor grades. SNRPB/D1/D2/D3/F/G expression was significantly correlated with cancer staging, whereas SNRPE was not. Moreover, Kaplan-Meier survival analysis showed that upregulation of SNRPB/D1/D2/E/G was relevant to worse OS in HCC patients, especially in patients with alcohol consumption and those without viral hepatitis. Multivariate Cox regression analysis indicated that expression of SNRPB/D1/D3/E/F/G were independent prognostic factors for unfavorable OS in HCC. In addition, a high mutation rate of snRNPs genes (44%) was also found in HCC. The mRNA expression levels of snRNPs were meaningfully and positively related to six types of infiltrating immune cells (B cells, CD4+ T cells, CD8+ T cells, neutrophil, macrophage, and dendritic cells). Also, SNRPB/D1/G genes were significantly associated with molecular markers of various immune cells in HCC. CONCLUSIONS: SNRPB/D1/D3/E/F/G are potential prognostic biomarkers for a short OS in HCC, and SNRPB/D1/G were novel immune therapy targets in HCC patients.

2.
Prog Neurobiol ; 184: 101721, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31704315

RESUMEN

Although exogenous nerve growth factor (NGF) demonstrated great potential for post-traumatic stress disorder (PTSD) treatment, its therapeutic effect and underlying cytological mechanism were not fully elucidated so far. We employed a controlled, prospectively designed modified single prolonged stress mice model to investigate the role of exogenous NGF on the modified single prolonged stress induced PTSD-like symptoms and hippocampal cytoarchitecture impairment, as well as the potential neuronal signaling modulation. We discovered that the modified single prolonged stress-exposure induced significant PTSD-like symptoms as well as mildly impaired hippocampal Cornu Ammonis 1 (CA1) subregion cytoarchitecture, but not dentate gyrus neurogenesis, together with a gradual inhibition of TrkA-CREB-ERK signalings in hippocampal CA1 subregion. NGF treatment dose-dependently ameliorated the modified single prolonged stress induced PTSD-like symptoms. NGF increased the cytoplasm/nucleus ratio and improved the neuronal plasticity, mainly via the TrkA-ERK-CREB pathway. Our study offered the translational evidence for the potential application of exogenous NGF for treating or early preventing PTSD after stress exposure.


Asunto(s)
Región CA1 Hipocampal/efectos de los fármacos , Factor de Crecimiento Nervioso/farmacología , Plasticidad Neuronal/efectos de los fármacos , Células Piramidales/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Trastornos por Estrés Postraumático/tratamiento farmacológico , Animales , Conducta Animal/efectos de los fármacos , Región CA1 Hipocampal/citología , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Modelos Animales de Enfermedad , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Factor de Crecimiento Nervioso/administración & dosificación , Receptor trkA/metabolismo
3.
Int J Neuropsychopharmacol ; 19(2)2015 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-26232790

RESUMEN

BACKGROUND: White matter disturbances and myelin impairment are key features of schizophrenia. The antipsychotic drug quetiapine can promote the maturation of oligodendrocytes, but the molecular mechanisms remain largely unknown. METHODS: The schizophrenia-like behaviors, degrees of demyelination, and levels of Notch signaling molecules in forebrains of adult male C57BL/6 mice were examined after fed with cuprizone (0.2% wt/wt) in the presence or absence of 10mg/kg/d quetiapine for 6 weeks. These parameters were also observed after the transcranial injection of Notch signaling inhibitor MW167 (1mM) daily during the last week of the treatment period. RESULTS: Quetiapine ameliorated the schizophrenia-like behaviors and decreased expression of myelin basic protein and inhibition of Notch signaling molecules, such as Notch1, Hes1, and Hes5, in the forebrain that induced by cuprizone. These beneficial effects of quetiapine were abolished by MW167. CONCLUSIONS: The antipsychotic and myelin protective effects of quetiapine are mediated by Notch signaling in a mouse model of cuprizone-induced demyelination associated with schizophrenia-like behaviors. The Notch pathway might therefore be a novel target for the development of antipsychotic drugs.


Asunto(s)
Cuprizona/toxicidad , Enfermedades Desmielinizantes/metabolismo , Fumarato de Quetiapina/administración & dosificación , Receptores Notch/metabolismo , Esquizofrenia/tratamiento farmacológico , Esquizofrenia/metabolismo , Animales , Enfermedades Desmielinizantes/patología , Enfermedades Desmielinizantes/prevención & control , Inyecciones Intraventriculares , Masculino , Ratones , Ratones Endogámicos C57BL , Vaina de Mielina/efectos de los fármacos , Vaina de Mielina/metabolismo , Vaina de Mielina/patología , Fármacos Neuroprotectores/administración & dosificación , Péptidos/farmacología , Receptores Notch/antagonistas & inhibidores , Esquizofrenia/patología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología
4.
Int J Clin Exp Med ; 7(7): 1757-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25126176

RESUMEN

Primary malignant melanoma of the lung is a very rare disease with about 40 cases reported in English literature. We report a 49-year-old female with history of 2 month chest pain who was revealed to have a peripheral lung mass in left upper lobe by chest CT scan. Left upper lobectomy was performed and post-operative pathology revealed to be primary malignant melanoma of the lung. 4 months after operation, a node in right breast was found by patient herself and needle aspiration biopsy revealed to be breast cancer. The patient refused any diagnostic and therapeutic procedure and died of extensive metastasis 3 months later. Primary malignant melanoma of the lung is highly malignant disease with poor prognosis in most patients.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA